Cefuroxime Impurity 6 | CAS 26924-74-3 - Request Quote
Cefuroxime Impurity 6
| SZ CAT No: | SZ-C086043 |
| CAS No | 26924-74-3 |
| Mol.F. | C14H19N3O6S |
| Mol.Wt. | 357.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cefuroxime Impurity 6 is chemically (6R,7R)-7-((R)-5-Amino-5-carboxypentanamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefuroxime Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Cefuroxime Impurity 6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefuroxime.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 26924-74-3
Purchase 26924-74-3
Order 26924-74-3
Enquire 26924-74-3
price of 26924-74-3
26924-74-3 Supplier
26924-74-3 Manufacturer
26924-74-3 Exporter
buy high quality Cefuroxime Impurity 6
Purchase Cefuroxime Impurity 6
Cefuroxime Impurity 6 suppliers
Cefuroxime Impurity 6 manufacturers
Cefuroxime Impurity 6 price
Order Cefuroxime Impurity 6
Enquire Cefuroxime Impurity 6
Cefuroxime Impurity 6 cost
Cefuroxime Impurity 6 Supplier
Cefuroxime Impurity 6 Distributor
Cefuroxime Impurity 6 for Method Validation
Cefuroxime Reference Standard
Cefuroxime Impurity 6 for ANDA Filing
Cefuroxime Impurity 6 for Forced Degradation Studies
Cefuroxime Impurity 6 Identification Standards
Cefuroxime Impurity 6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.